Health Worlds

Mesothelioma, there are two: pleural mesothelioma and peritoneal mesothelioma.
A: pleural mesothelioma is pleural primary tumor, a localized (mostly benign) and diffuse (all malignant) points. Diffuse malignant mesothelioma is one of the worst prognosis breast tumors. Most patients in the 40-70 years old, more men than women. The first symptom of chest pain, cough and shortness of breath is the most common. Have fever, sweating or joint pain mainly v. symptoms. About half of the patients had large pleural effusion and severe shortness of breath. No large pleural effusion are often more severe chest pain, weight loss common. Ordinary X-ray found that pleural effusion, and lung tumor tissue was wrapped so advanced cases may have pericardial effusion caused by heart shadow expansion and soft tissue and rib destruction. For patients with suspected malignant pleural mesothelioma, CT examination is most useful. Pleural fluid cytology are diagnostic. Routine laboratory tests, some patients may have thrombocytosis, serum carcinoembryonic antigen (CEA) level rise. For routine examination the diagnosis is not clear, can do thoracoscopic pleural biopsy. General most patients can thus be diagnosed.
The treatment of malignant pleural mesothelioma, there is still no effective cure. Treatment, there are palliative treatment, surgical treatment, chemotherapy and radiation therapy is generally believed that the tumor of patients with relatively limited I advocate doing radical pleur


al pneumonectomy. For , , stage patients, radical surgery has no meaning, only the implementation of palliative surgery. In fact, the majority of patients to disease diagnosis, has been in II, above. Pleural effusion often leads to rapid growth in patients with severe breathing difficulties, so palliative surgery for improving the quality of life of these terminally ill patients is significant. Previously used intrapleural chemotherapy drugs such as pleural effusion or cause regression method of closed pleural adhesion is often difficult to work.
II: Primary peritoneal mesothelioma is peritoneal mesothelial cells in the tumor. Does not have the characteristic clinical manifestations, common signs and symptoms include: abdominal pain, ascites, abdominal distention and abdominal mass, and so on. Peritoneal mesothelioma accounts for about 20% of all mesothelioma cases, can occur in 2-92 years, mean age was 54 years old, of which about 63% of cases in the 45-64 years of age, children are rarely sick. Clinical manifestations 1. Abdominal pain, abdominal distension, ascites, abdominal mass; 2. Anorexia, nausea, vomiting, diarrhea, constipation; 3. Fatigue, fever, weight loss, anemia; 4. Low blood sugar, diffuse abdominal ossification; 5. combined with other parts, such as peritoneal mesothelioma, mesothelioma, metastasis to other organs and complications of the corresponding performance. Diagnosis is based . Abdominal pain, abdominal distension, ascites, abdominal mass in patients, especially those with asbestos exposure history; 2. Peritoneal imaging signs of a thin sheet of tumor and ascites; 3. Ascites cytology; 4. Peritoneal biopsy laparoscopy and laparotomy and took tissue for pathological examination can be confirmed. Peritoneal mesothelioma originated in the peritoneal epithelium and mesothelial tissue, asbestos dust as a pathogenic substances may also be caused by certain viruses cause of mesothelioma. Pathology of peritoneal mesothelioma can be divided into: adenomatoid tumor, cystic mesothelioma, and malignant mesothelioma of three. Peritoneal mesothelioma clinical manifestations are not specific, the check-positive rate is not high, specificity is not strong, clinical diagnosis very difficult. With laparoscopy, ultrasound and CT guided biopsy technology, carry out and pathology, immunohistochemistry and electron microscopic diagnosis level, more and more cases are clearly alive and preoperative pathological diagnosis. Peritoneal mesothelioma should primarily with tuberculous peritonitis, intra-abdominal metastases, other primary tumors in the peritoneal omentum differentiated.
Pericardial Mesothelioma is a rare primary cardiac tumors, usually malignant tumor of adult, mainly mesothelioma. Because the disease progression, conceal, no specific clinical features, easily misdiagnosed. If you could be inflated pericardial imaging, cardiac CT examination or determination of hyaluronic acid in pericardial fluid for early diagnosis of pericardial mesothelioma have a certain value. The disease usually require surgical exploration to take biopsy examination to diagnose disease, in this case finally confirmed by pathology. Disease prognosis is poor, There is no specific treatment, according to the specific circumstances of radiotherapy, chemotherapy and symptomatic treatment to alleviate the condition, alleviate the suffering of patients.
Pleural mesothelioma is pleural primary tumor, a localized (mostly benign) and diffuse (all malignant) points. Diffuse malignant mesothelioma is one of the worst prognosis breast tumors. Most patients in the 40-70 years old, more men than women. The first symptom of chest pain, cough and shortness of breath is the most common. Have fever, sweating or joint pain mainly v. symptoms. About half of the patients had large pleural effusion and severe shortness of breath. No large pleural effusion are often more severe chest pain, weight loss common. Ordinary X-ray found that pleural effusion, and lung tumor tissue was wrapped so advanced cases may have pericardial effusion caused by heart shadow expansion and soft tissue and rib destruction. For patients with suspected malignant pleural mesothelioma, CT examination is most useful. Pleural fluid cytology are diagnostic. Routine laboratory tests, some patients may have thrombocytosis, serum carcinoembryonic antigen (CEA) level rise. For routine examination the diagnosis is not clear, can do thoracoscopic pleural biopsy. General most patients can thus be diagnosed.
The treatment of malignant pleural mesothelioma is still no effective cure. Treatment, there are palliative treatment, surgical treatment, chemotherapy and radiation therapy is generally believed that the tumor of patients with relatively limited I advocate doing radical pleural pneumonectomy. For , , stage patients, radical surgery has no meaning, only the implementation of palliative surgery. In fact, the majority of patients to disease diagnosis, has been in II, above. Pleural effusion often leads to rapid growth in patients with severe breathing difficulties, so palliative surgery for improving the quality of life of these terminally ill patients is significant. Previously used intrapleural chemotherapy drugs such as pleural effusion or cause regression method of closed pleural adhesion is often difficult to work. With thoracoscopic pleurodesis in malignant pleural mesothelioma in the palliative treatment achieved good results, will be assisted thoracic surgery for pleural aspiration completely clean, and full separation of adhesions, the lung recruitment, and then sprayed into the sterilized talc powder, the pleurodesis to control the production of pleural effusion, relief of clinical symptoms in patients with advanced cancer.


Friends Links:Automation Control Blog
Automation Products Order Numbers